Styl cytowania APA

Recondo, G., Mezquita, L., Facchinetti, F., Planchard, D., Gazzah, A., Bigot, L., . . . Friboulet, L. (2019). Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer. Clin Cancer Res.

Styl cytowania Chicago

Recondo, Gonzalo, et al. "Diverse Resistance Mechanisms to the Third-generation ALK Inhibitor Lorlatinib in ALK-rearranged Lung Cancer." Clin Cancer Res 2019.

Styl cytowania MLA

Recondo, Gonzalo, et al. "Diverse Resistance Mechanisms to the Third-generation ALK Inhibitor Lorlatinib in ALK-rearranged Lung Cancer." Clin Cancer Res 2019.

Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..